non glp 1 drugs for weight loss Compound versions of GLP-1 halted by FDA The New Weight Management Meds

J Korean Endocr Soc 2006;21:43747.Article 5

May offer cardiovascular protection, with possible reductions in cases of major adverse cardiovascular events (MACE) such as myocardial infarction and stroke in high-risk populations 23

If we allow ourselves to truly recognize the scale of the numbers above, the deaths from addiction that happen year after year after year, and if we believe that GLP-1s have a high likelihood of efficacy and are positioned to reach a far larger percentage of SUD patients than existing medications, we should take coordinated action now

5), S42S47 (2001)

Micro-dosing just means using smaller doses than what's recommended by the company when you read the package insert

Nakamura T, Iwanaga Y, Miyaji Y, Nohara R, Ishimura T, Miyazaki S, et al